ConductScience.org, home

Trial · NCT04741880

Registered outcomes18

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryTime to T12 regression of the sensory blockPeriod: Day 0 postoperativeTime between the injection of bupivacaine into the subarachnoid space and the regression of sensory block to T12 dermatome (in minutes)
SecondaryTime to motor block regressionDay 0 postoperativeTime between the injection of bupivacaine into the subarachnoid space and the regression of motor block to the modified Bromage scale 1 (in minutes)
SecondaryMost rostral dermatome achieved by the sensory blockDay 0 postoperativeEvaluated as ordinal variable (see statistical analysis)
SecondaryTime to two-segment regression of the sensory blockDay 0 postoperativeTime between the injection of bupivacaine into the subarachnoid space and the regression of 2 dermatomes sensory block level (in minutes)
SecondaryPropofol dose at the operating roomIntraoperativeIn mg
SecondaryTime to the first opioid rescueIntraoperativeIn mg
SecondaryPostoperative pain score at restAdmission to the PACU, 2 postoperative hours, 24 postoperative hours, and worse in the first 24 postoperative hours measurementsVerbal numerical scale between 0 and 10, being 0 = "no pain" and 10 = "worst pain imaginable"
SecondaryPain score at movement24 postoperative hoursVerbal numerical scale between 0 and 10, being 0 = "no pain" and 10 = "worst pain imaginable"
SecondaryQuality of recovery in 24 hours24 postoperative hoursQuality of recovery measured by the "40-item quality-of-recovery questionnaire" (QoR-40)
SecondaryNeed for opioid analgesics (binary)Between 0 and 6 postoperative hours, between 6 and 24 postoperative hours, and between 0 and 24 postoperative hoursYES/NO
SecondaryNeed for opioid analgesics (continuous)between 0 and 6 postoperative hours, between 6 and 24 postoperative hours, and between 0 and 24 postoperative hoursIn oral morphine equivalents (in mg)
SecondaryNausea or vomitingBetween 0 and 6 postoperative hours, between 6 and 24 postoperative hours, and between 0 and 24 postoperative hoursPresence of nausea or vomiting reported by the patient - YES/NO
SecondaryDizzinessFrom intraoperative to 24 postoperative hoursReport of dizziness by patient - YES/NO
SecondaryBradycardiaAt the operating room (OR) and admission to the PACU up to 24 postoperative hoursHeart rate below 50 beats per minute (YES/NO)
SecondaryOther arrhythmiasAt the OR and admission to the PACU up to 24 postoperative hoursHeart rhythm change except sinus bradycardia and sinus tachycardia (YES/NO)
SecondaryHypotensionAt the OR, between 0 and 6 postoperative hours, between 6 and 24 postoperative hours, and between 0 and 24 postoperative hoursMAP \< 65mmHg or presence of compatible symptoms (such as nausea, vomiting or cognitive impairments)
SecondaryUrinary retentionBetween 0 and 24 postoperative hoursVoiding difficulty that requires bladder catheterization for relief by the assistant team
SecondaryLength of stayThrough study completion, an average of 30 daysTime between the end of the operation and administrative discharge in days

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04741880/registered